# MedImmune Ventures' Biotech Investments: 10 Startups in Its Portfolio (2026) > The 10 Biotech startups MedImmune Ventures has backed, by stage: $1.1B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/medimmune-ventures-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 4 - [*LP* LigoCyte Pharmaceuticals](https://millionrounds.com/company/ligocyte-pharmaceuticals) - [Virdante Pharmaceuticals](https://millionrounds.com/company/virdante-pharmaceuticals) - [*AT* Altiris Therapeutics](https://millionrounds.com/company/altiris-therapeutics) - [*NT* NKT Therapeutics](https://millionrounds.com/company/nkt-therapeutics) ## Series C and later 4 - [ADC Therapeutics](https://millionrounds.com/company/adc-therapeutics) - [Hydra Biosciences](https://millionrounds.com/company/hydra-biosciences) - [Inotek Pharmaceuticals](https://millionrounds.com/company/inotek-pharmaceuticals) - [*IC* Iomai Corporation](https://millionrounds.com/company/iomai-corporation) ## Series B 2 - [*C* Corvidia](https://millionrounds.com/company/corvidia) - [Coferon](https://millionrounds.com/company/coferon) ## Segment by segment ### Stage not reported 4 startups · $188M raised - [*LP* **LigoCyte Pharmaceuticals**](https://millionrounds.com/company/ligocyte-pharmaceuticals) LigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibodies for gastrointestinal and respiratory indications. United States $72M - [**Virdante Pharmaceuticals**](https://millionrounds.com/company/virdante-pharmaceuticals) Virdante Pharmaceuticals is a biopharmaceutical company developing and commercializing drugs for autoimmune and inflammatory diseases. United States $60M - [*AT* **Altiris Therapeutics**](https://millionrounds.com/company/altiris-therapeutics) Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer. United States $44M - [*NT* **NKT Therapeutics**](https://millionrounds.com/company/nkt-therapeutics) NKT Therapeutics is a privately held biotechnology company focused on developing therapeutics to treat cancer and other serious diseases. United States $12M ### Series C and later 4 startups · $864M raised - [**ADC Therapeutics**](https://millionrounds.com/company/adc-therapeutics) ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products. Switzerland $646M - [**Hydra Biosciences**](https://millionrounds.com/company/hydra-biosciences) Hydra Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, founded in 2001. United States $95M - [**Inotek Pharmaceuticals**](https://millionrounds.com/company/inotek-pharmaceuticals) Inotek Pharmaceuticals develops drug candidates to address significant diseases of the eye. United States $70M - [*IC* **Iomai Corporation**](https://millionrounds.com/company/iomai-corporation) Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology call United States $54M ### Series B 2 startups · $89M raised - [*C* **Corvidia**](https://millionrounds.com/company/corvidia) Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases. United States $61M - [**Coferon**](https://millionrounds.com/company/coferon) Coferon employs bioorthogonal linker chemistry to deliver therapeutic molecules in component parts that self assembles inside target cells. United States $28M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names MedImmune Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Coinbase Ventures' Web3 & Crypto portfolio** 168 startups · $5.7B](https://millionrounds.com/portfolio-maps/coinbase-web3-crypto-portfolio)[Sector portfolio **Salesforce Ventures' AI portfolio** 115 startups · $181B](https://millionrounds.com/portfolio-maps/salesforce-ventures-ai-portfolio)[Sector portfolio **Google Ventures' AI portfolio** 81 startups · $16B](https://millionrounds.com/portfolio-maps/gv-ai-portfolio)[Sector portfolio **Google Ventures' Biotech portfolio** 74 startups · $12B](https://millionrounds.com/portfolio-maps/gv-biotech-portfolio)[Sector portfolio **Samsung Next's AI portfolio** 72 startups · $9.8B](https://millionrounds.com/portfolio-maps/samsung-next-ai-portfolio)[Sector portfolio **Endeavor Catalyst's Fintech portfolio** 65 startups · $9.9B](https://millionrounds.com/portfolio-maps/endeavor-catalyst-fintech-portfolio) ## Raising from investors like MedImmune Ventures? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)